FindTrial
Sign In

Comparative study on detection efficiency of tumor NTRK fusion mutation

Comparative study on detection efficiency of tumor NTRK fusion mutation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066850
Enrollment
Unknown
Registered
2022-12-20
Start date
2021-10-26
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pan-solid tumor

Interventions

Reference interval group:No intervention
The cutoff value group:No intervention

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Unlimited gender and age; 2. Solid tumor-like tissue samples without limiting tumor species; 3. Tumor tissue samples have been tested by NGS/FISH/PCR to confirm the NTRK fusion status; 4. Informed consent shall be obtained from patients in accordance with local laws and regulations, or approval shall be obtained to avoid informed consent.

Exclusion criteria

Exclusion criteria: 1. Tumors with NTRK protein expression but without NTRK gene fusion; 2. The amount of tumor tissue in the specimen is too small or the sample quality cannot meet the assessment requirements.

Design outcomes

Primary

MeasureTime frame
pan-TRK IHC staining results;—

Countries

China

Contacts

Public ContactZhiyong Liang

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

liangzy@pumch.cn13701076576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026